Qube Research & Technologies (QRT)
VRCA icon

Qube Research & Technologies (QRT)’s Verrica Pharmaceuticals VRCA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,296
Closed -$28.1K – 4069
2025
Q2 		$28.1K Buy
+5,296
New +$28.5K ﹤0.01% 3226
2025
Q1 		– Sell
-3,526
Closed -$24.7K – 3993
2024
Q4 		$24.7K Sell
3,526
-28,693
-89% -$315K ﹤0.01% 3166
2024
Q3 		$467K Buy
+32,219
New +$1.45M ﹤0.01% 2293
2023
Q2 		– Sell
-5,409
Closed -$352K – 3082
2023
Q1 		$352K Buy
+5,409
New +$327K ﹤0.01% 1690
2022
Q4 		– Sell
-1,102
Closed -$32K – 3040
2022
Q3 		$32K Sell
1,102
-33
-3% -$1.13K ﹤0.01% 2223
2022
Q2 		$22K Buy
+1,135
New +$57K ﹤0.01% 2255

Other funds holding VRCA

CP
Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return